American Oncology Network Inc (AONC) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket
 


American Oncology Network Inc   (AONC)


American Oncology Network Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is American Oncology Network Inc's ROI in the fourth quarter of 2024?
American Oncology Network Inc recorded a cumulative net loss of $-27 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -27.08%.

Within the Healthcare sector 322 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 3110 to 3336.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM 64.39 % -35.81 % -49.48 % -71.41 % -82.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 140 86 88 83 101
Return On Investment (TTM) -27.08 % -38.61 % -35.93 % -53.7 % -30.73 %
AONC's Overall Ranking # 3336 # 3110 # 2815 # 2711 # 3171
Seq. Investment Change TTM 11.12 % -8.31 % 24.66 % 29.42 % -56.61 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -35 -35 -42 -19




Return On Investment AONC's Ranking
Within: No.
Industry # 106
Sector # 323
Overall # 3336

Return On Investment Statistics
High Average Low
3.69 %
-20.89 %
-81.13 %
(Mar 31 2022)   (Mar 31 2024)



  News about American Oncology Network Inc Return on Investment ROI

American Oncology Network Taps Seasoned Financial Leader David Afshar to Overhaul Financial Operations and Drive Growth

June 3, 2024


American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer
American Oncology Network Inc. (AON), a leading healthcare company in the oncology sector, has announced the appointment of David Afshar as the Chief Financial and Operating Officer. With his vast experience and expertise in the financial industry, Afshar is expected to lead the company s financial and operating strategies and help drive its growth in the coming years.
AON is known for its comprehensive oncology services, providing cancer treatment and care to patients across the United States. However, recent financial data from the company reveals concerning figures regarding its bottom line. According to the records, AON experienced a net loss of $88 million during the 12-month period ending in the first quarter of 2024. This resulted in a negative return on investment (ROI) of -112.67% for the same period.






Financial Statements
American Oncology Network Inc's IV. Quarter Investments $ 140 Millions AONC's Balance sheet
American Oncology Network Inc's IV. Quarter Income $ 2 Millions Quarterly AONC's Income Statement
AONC's Income by Division See AONC's Income by Division


AONC Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021

Total Investments in Millions 140 101 336 334 0
Y / Y Investment Growth 39.61 % -70.08 % 0.73 % - -
Net Income in Millions -27 -63 11 8 0
Y / Y Net Income Growth - - 25.47 % - -
Annual Return On Investment -19.19 % -62.76 % 3.13 % 2.51 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AONC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AONC's Competitors
Subscribers only: Roi for American Oncology Network Inc's Suppliers
Subscribers only: Return On Investment for AONC's Customers

Other Ratios
AONC's Roa AONC's Inventory Turnover Ratio AONC's Growth Rates AONC's Dividend Statistics
AONC's Profitability Ratios AONC's Asset Turnover Ratio AONC's Dividend Growth
AONC's Roe AONC's Valuation Ratios AONC's Financial Strength Ratios AONC's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.